Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Evaluation of Dermacyd Delicata New Fragrance
NCT00370162Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lactoserum, sponsored by Sanofi. Primary endpoint: Adverse Events and its association with the drug in study at 21 days. Started Jun 2006; status: completed.
02
Drugs
lactoserum
Beyond the preview
Go deeper on NCT00370162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370162.